WHO Adds ArkBio's Ziresovir to Priority Pediatric RSV Drug List, A First from China ArkBio's Ziresovir has been recognized by WHO in its PADO-RSV pediatric drug priority list, marking a milestone as the first Chinese antiviral drug for RSV.

WHO Adds ArkBio's Ziresovir to Priority Pediatric RSV Drug List, A First from China #China #Shanghai #RSV #ArkBio #Ziresovir